{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:14:49Z","timestamp":1778580889436,"version":"3.51.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Approximately 1\u20132% of patients undergoing hip or knee arthroplasty encounter a periprosthetic joint infection (PJI). Currently, the treatment involves revision surgeries and long-term antibiotic therapy. However, too low antibiotic concentrations can lead to treatment failure, whereas excessively high concentrations can lead to adverse events. Although optimal dosing is very important, there remains an insufficient understanding of the relationship between the concentrations of the plasma and antibiotics at the target site. This study aimed to develop and validate a novel ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS\/MS) technique for quantifying two frequently prescribed antibiotics, vancomycin and clindamycin, in synovial tissue and bone samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Method validation was performed based on the guidelines of the European Medicines Agency (EMA) and US Food and Drug Administration (FDA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The method was found linear for vancomycin from 0.8 to 25 \u03bcg\/g and for clindamycin from 0.5 to 25 \u03bcg\/g in the bone and from 1 to 25 \u03bcg\/g for both compounds in synovial tissue (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      &gt; 0.990). The results of the validation of precision, accuracy, and carry-over were all within the acceptable ranges. All clindamycin extracts were stable in the autosampler for the bone and synovial tissue samples for up to 24 hours. Vancomycin extracts were stable in synovial tissue for up to 24 hours but not in bone sample extracts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>A method for quantifying vancomycin and clindamycin in synovial tissue and bone using UHPLC-MS\/MS was developed and validated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001381","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T12:04:11Z","timestamp":1757073851000},"page":"331-339","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Quantification of Vancomycin and Clindamycin in Synovial Tissue and Bone Using Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry"],"prefix":"10.1097","volume":"48","author":[{"given":"Amanda J.","family":"Holst","sequence":"first","affiliation":[{"name":"Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soma","family":"Bahmany","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela C. J.","family":"van Dorp","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"van Oldenrijk","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Surgery, and Sports Medicine, Erasmus MC, Univeristy Medical Center Rotterdam, Rotterdam, the Netherlands; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Koen","family":"Bos","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Surgery, and Sports Medicine, Erasmus MC, Univeristy Medical Center Rotterdam, Rotterdam, the Netherlands; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewout S.","family":"Veltman","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Surgery, and Sports Medicine, Erasmus MC, Univeristy Medical Center Rotterdam, Rotterdam, the Netherlands; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda C. M.","family":"de Winter","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands;"},{"name":"CATOR, Center for Antimicrobial Treatment Optimization Rotterdam, Rotterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit C. P.","family":"Koch","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands;"},{"name":"CATOR, Center for Antimicrobial Treatment Optimization Rotterdam, Rotterdam, the Netherlands."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"R3-20260508","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.00111-13","article-title":"Prosthetic joint infection","volume":"27","author":"Tande","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"R4-20260508","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/aoj-20-85","article-title":"Biofilm formation in periprosthetic joint infections","volume":"6","author":"Staats","year":"2021","journal-title":"Ann Jt"},{"key":"R5-20260508","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0140-6736(14)61798-0","article-title":"Periprosthetic joint infection","volume":"387","author":"Kapadia","year":"2016","journal-title":"Lancet"},{"key":"R6-20260508","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12178-018-9495-y","article-title":"Two-stage revision arthroplasty for the treatment of prosthetic joint infection","volume":"11","author":"Charette","year":"2018","journal-title":"Curr Rev Musculoskelet Med"},{"key":"R7-20260508","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13063-016-1213-8","article-title":"One-stage or two-stage revision surgery for prosthetic hip joint infection \u2013 the INFORM trial: a study protocol for a randomised controlled trial","volume":"17","author":"Strange","year":"2016","journal-title":"Trials"},{"key":"R8-20260508","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1302\/0301-620X.103B.BJJ-2020-1480.R2","article-title":"One-stage revision is as effective as two-stage revision for chronic culture-negative periprosthetic joint infection after total hip and knee arthroplasty","volume":"103-B","author":"Van Den Kieboom","year":"2021","journal-title":"Bone Joint J"},{"key":"R9-20260508","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10654-018-0377-9","article-title":"One- and two-stage surgical revision of peri-prosthetic joint infection of the hip: a pooled individual participant data analysis of 44 cohort studies","volume":"33","author":"Kunutsor","year":"2018","journal-title":"Eur J Epidemiol"},{"key":"R10-20260508","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00264-019-04426-7","article-title":"Twenty common errors in the diagnosis and treatment of periprosthetic joint infection","volume":"44","author":"Li","year":"2020","journal-title":"Int Orthop"},{"key":"R11-20260508","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3390\/antibiotics12121738","article-title":"Effective antimicrobial prophylaxis in surgery: the relevance and role of pharmacokinetics-pharmacodynamics","volume":"12","author":"Zelenitsky","year":"2023","journal-title":"Antibiotics"},{"key":"R12-20260508","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/17512433.2019.1621161","article-title":"Antibiotic exposure at the site of infection: principles and assessment of tissue penetration","volume":"12","author":"Jager","year":"2019","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R13-20260508","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","article-title":"Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations","volume":"48","author":"Landersdorfer","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"R14-20260508","doi-asserted-by":"crossref","first-page":"124169","DOI":"10.1016\/j.jchromb.2024.124169","article-title":"Quantification of cefuroxime and flucloxacillin in synovial tissue and bone using ultra-performance convergence chromatography-tandem mass spectrometry","volume":"1241","author":"Bahmany","year":"2024","journal-title":"J Chromatogr B Anal Tech Biomed Life Sci"},{"key":"R15-20260508","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF01617045","article-title":"Internal mammary artery harvesting and antibiotic concentrations in sternal bone during coronary artery bypass","volume":"9","author":"Vuorisalo","year":"2000","journal-title":"Int J Angiol"},{"key":"R16-20260508","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.32.9.1320","article-title":"Vancomycin concentrations in infected and noninfected human bone","volume":"32","author":"Graziani","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-20260508","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1128\/AAC.36.11.2539","article-title":"Penetration of vancomycin in uninfected sternal bone","volume":"36","author":"Massias","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"R18-20260508","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/AAC.38.2.396","article-title":"Penetration of vancomycin into mediastinal and cardiac tissues in humans","volume":"38","author":"Martin","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"R19-20260508","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00007691-200012000-00004","article-title":"Pharmacokinetics of vancomycin administered as prophylaxis before cardiac surgery","volume":"22","author":"Kitzes-Cohen","year":"2000","journal-title":"Ther Drug Monit"},{"key":"R20-20260508","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17453674.2017.1373497","article-title":"Bone and subcutaneous adipose tissue pharmacokinetics of vancomycin in total knee replacement patients","volume":"89","author":"Bue","year":"2018","journal-title":"Acta Orthop"},{"key":"R21-20260508","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9872.1000196","article-title":"Determination of vancomycin in human plasma, bone and fat by liquid chromatography\/tandem mass spectrometry","volume":"5","author":"Zhang","year":"2014","journal-title":"J Anal Bioanal Tech"},{"key":"R22-20260508","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/AAC.8.2.220","article-title":"Concentration of clindamycin in human bone","volume":"8","author":"Nicholas","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-20260508","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0300-9785(78)80035-0","article-title":"Concentrations of azidocillin, erythromycin, doxycycline and clindamycin in human mandibular bone","volume":"7","author":"Bystedt","year":"1978","journal-title":"Int J Oral Surg"},{"key":"R24-20260508","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/3.2.153","article-title":"Antibacterial activity of clindamycin and lincomycin in human bone","volume":"3","author":"Dornbusch","year":"1977","journal-title":"J Antimicrob Chemother"},{"key":"R25-20260508","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.jchromb.2011.07.018","article-title":"Comparative study of the LC-MS\/MS and UPLC-MS\/MS for the multi-residue analysis of quinolones, penicillins and cephalosporins in cow milk, and validation according to the regulation 2002\/657\/EC","volume":"879","author":"Junza","year":"2011","journal-title":"J Chromatogr B, Anal Tech Biomed Life Sci"},{"key":"R27-20260508","doi-asserted-by":"crossref","first-page":"123493","DOI":"10.1016\/j.jchromb.2022.123493","article-title":"Quantification of vancomycin and clindamycin in human plasma and synovial fluid applying ultra-performance liquid chromatography tandem mass spectrometry","volume":"1212","author":"Ringeling","year":"2022","journal-title":"J Chromatogr B, Anal Tech Biomed Life Sci"},{"key":"R31-20260508","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/24.suppl_B.93","article-title":"Penetration of amoxycillin\/clavulanate into human bone","volume":"24","author":"Weismeier","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"R32-20260508","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jac\/dkh191","article-title":"Antibiotic treatment of Gram-positive bone and joint infections","volume":"53","author":"Darley","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"R33-20260508","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/17425255.2022.2117607","article-title":"The mysteries of target site concentrations of antibiotics in bone and joint infections: what is known? A narrative review","volume":"18","author":"Koch","year":"2022","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R34-20260508","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","article-title":"Antibiotic penetration into bone and joints: an updated review","volume":"81","author":"Thabit","year":"2019","journal-title":"Int J Infect Dis"},{"key":"R35-20260508","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00003086-197509000-00019","article-title":"Antibiotic bone penetration. Concentrations of methicillin and clindamycin phosphate in human bone taken during total hip replacement","volume":"111","author":"Schurman","year":"1975","journal-title":"Clin Orthopaedics Relat Res"},{"key":"R36-20260508","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1128\/AAC.9.1.169","article-title":"Bone concentrations of antimicrobial agents after parenteral administration","volume":"9","author":"Smilack","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"R37-20260508","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1010-5182(99)80046-8","article-title":"Perioperative antibiotic prophylaxis in maxillofacial surgery: penetration of clindamycin into various tissues","volume":"27","author":"Mueller","year":"1999","journal-title":"J Craniomaxillofac Surg"},{"key":"R38-20260508","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/pgmj.54.628.65","article-title":"Penetration into bone and tissues of clindamycin phosphate","volume":"54","author":"Baird","year":"1978","journal-title":"Postgrad Med J"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:42:41Z","timestamp":1778578961000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001381","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"2025-03-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}